The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex
Parkinson’s disease (PD) is a complex pathology causing a plethora of non-motor symptoms besides classical motor impairments, including cognitive disturbances. Recent studies in the PD human brain have reported microgliosis in limbic and neocortical structures, suggesting a role for neuroinflammation in the development of cognitive decline. Yet, the mechanism underlying the cognitive pathology is under investigated, mainly for the lack of a valid preclinical neuropathological model reproducing the disease’s motor and non-motor aspects. Here, we show that the bilateral intracerebral infusion of pre-formed human alpha synuclein oligomers (H-αSynOs) within the substantia nigra pars compacta (SNpc) offers a valid model for studying the cognitive symptoms of PD, which adds to the classical motor aspects previously described in the same model. Indeed, H-αSynOs-infused rats displayed memory deficits in the two-trial recognition task in a Y maze and the novel object recognition (NOR) test performed three months after the oligomer infusion. In the anterior cingulate cortex (ACC) of H-αSynOs-infused rats the in vivo electrophysiological activity was altered and the expression of the neuron-specific immediate early gene (IEG) <i<Npas4</i< (Neuronal PAS domain protein 4) and the AMPA receptor subunit GluR1 were decreased. The histological analysis of the brain of cognitively impaired rats showed a neuroinflammatory response in cognition-related regions such as the ACC and discrete subareas of the hippocampus, in the absence of any evident neuronal loss, supporting a role of neuroinflammation in cognitive decline. We found an increased GFAP reactivity and the acquisition of a proinflammatory phenotype by microglia, as indicated by the increased levels of microglial Tumor Necrosis Factor alpha (TNF-α) as compared to vehicle-infused rats. Moreover, diffused deposits of phospho-alpha synuclein (p-αSyn) and Lewy neurite-like aggregates were found in the SNpc and striatum, suggesting the spreading of toxic protein within anatomically interconnected areas. Altogether, we present a neuropathological rat model of PD that is relevant for the study of cognitive dysfunction featuring the disease. The intranigral infusion of toxic oligomeric species of alpha-synuclein (α-Syn) induced spreading and neuroinflammation in distant cognition-relevant regions, which may drive the altered neuronal activity underlying cognitive deficits..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Cells - 11(2022), 17, p 2628 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Maria Francesca Palmas [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
α-synuclein |
---|
doi: |
10.3390/cells11172628 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ084957042 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ084957042 | ||
003 | DE-627 | ||
005 | 20240414214740.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230311s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/cells11172628 |2 doi | |
035 | |a (DE-627)DOAJ084957042 | ||
035 | |a (DE-599)DOAJ3eedc67be715406cbd276027691c9ffd | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QH573-671 | |
100 | 0 | |a Maria Francesca Palmas |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Parkinson’s disease (PD) is a complex pathology causing a plethora of non-motor symptoms besides classical motor impairments, including cognitive disturbances. Recent studies in the PD human brain have reported microgliosis in limbic and neocortical structures, suggesting a role for neuroinflammation in the development of cognitive decline. Yet, the mechanism underlying the cognitive pathology is under investigated, mainly for the lack of a valid preclinical neuropathological model reproducing the disease’s motor and non-motor aspects. Here, we show that the bilateral intracerebral infusion of pre-formed human alpha synuclein oligomers (H-αSynOs) within the substantia nigra pars compacta (SNpc) offers a valid model for studying the cognitive symptoms of PD, which adds to the classical motor aspects previously described in the same model. Indeed, H-αSynOs-infused rats displayed memory deficits in the two-trial recognition task in a Y maze and the novel object recognition (NOR) test performed three months after the oligomer infusion. In the anterior cingulate cortex (ACC) of H-αSynOs-infused rats the in vivo electrophysiological activity was altered and the expression of the neuron-specific immediate early gene (IEG) <i<Npas4</i< (Neuronal PAS domain protein 4) and the AMPA receptor subunit GluR1 were decreased. The histological analysis of the brain of cognitively impaired rats showed a neuroinflammatory response in cognition-related regions such as the ACC and discrete subareas of the hippocampus, in the absence of any evident neuronal loss, supporting a role of neuroinflammation in cognitive decline. We found an increased GFAP reactivity and the acquisition of a proinflammatory phenotype by microglia, as indicated by the increased levels of microglial Tumor Necrosis Factor alpha (TNF-α) as compared to vehicle-infused rats. Moreover, diffused deposits of phospho-alpha synuclein (p-αSyn) and Lewy neurite-like aggregates were found in the SNpc and striatum, suggesting the spreading of toxic protein within anatomically interconnected areas. Altogether, we present a neuropathological rat model of PD that is relevant for the study of cognitive dysfunction featuring the disease. The intranigral infusion of toxic oligomeric species of alpha-synuclein (α-Syn) induced spreading and neuroinflammation in distant cognition-relevant regions, which may drive the altered neuronal activity underlying cognitive deficits. | ||
650 | 4 | |a Parkinson’s disease | |
650 | 4 | |a cognitive impairment | |
650 | 4 | |a neuroinflammation | |
650 | 4 | |a α-synuclein | |
650 | 4 | |a neuronal activity | |
650 | 4 | |a microglia | |
653 | 0 | |a Cytology | |
700 | 0 | |a Michela Etzi |e verfasserin |4 aut | |
700 | 0 | |a Augusta Pisanu |e verfasserin |4 aut | |
700 | 0 | |a Chiara Camoglio |e verfasserin |4 aut | |
700 | 0 | |a Claudia Sagheddu |e verfasserin |4 aut | |
700 | 0 | |a Michele Santoni |e verfasserin |4 aut | |
700 | 0 | |a Maria Francesca Manchinu |e verfasserin |4 aut | |
700 | 0 | |a Mauro Pala |e verfasserin |4 aut | |
700 | 0 | |a Giuliana Fusco |e verfasserin |4 aut | |
700 | 0 | |a Alfonso De Simone |e verfasserin |4 aut | |
700 | 0 | |a Luca Picci |e verfasserin |4 aut | |
700 | 0 | |a Giovanna Mulas |e verfasserin |4 aut | |
700 | 0 | |a Saturnino Spiga |e verfasserin |4 aut | |
700 | 0 | |a Maria Scherma |e verfasserin |4 aut | |
700 | 0 | |a Paola Fadda |e verfasserin |4 aut | |
700 | 0 | |a Marco Pistis |e verfasserin |4 aut | |
700 | 0 | |a Nicola Simola |e verfasserin |4 aut | |
700 | 0 | |a Ezio Carboni |e verfasserin |4 aut | |
700 | 0 | |a Anna R. Carta |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Cells |d MDPI AG, 2012 |g 11(2022), 17, p 2628 |w (DE-627)DOAJ000041742 |x 20734409 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2022 |g number:17, p 2628 |
856 | 4 | 0 | |u https://doi.org/10.3390/cells11172628 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/3eedc67be715406cbd276027691c9ffd |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2073-4409/11/17/2628 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2073-4409 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 11 |j 2022 |e 17, p 2628 |